Novartis India Limited has issued a regulatory disclosure intimating about an upcoming Analyst/Institutional Investor Meeting. The disclosure is made pursuant to Regulation 30 read with Schedule III Part A Para A sub-para 15 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The meeting details are as follows:
- Date: Friday, September 11, 2026
- Event Type: Investor/Analyst Call
- Time: 04:00 pm IST onwards
- Location: Mumbai
- Mode: Virtual and Physical both (hybrid format)
- Meeting Type: General Group Meeting
The company included a note that the schedule may undergo changes due to exigencies on the part of investors, analysts, or the company itself.
Interested participants are required to confirm their attendance by writing to investor.relations@nilpharma.co.in.
The company specifically stated that during the meeting, it will refer only to publicly available information and will not share any unpublished price sensitive information (UPSI).
A presentation related to the meeting will be made available before the event on the stock exchange (BSE Limited) and on the company's website at https://nilpharma.co.in/.